1-9 of 9
Morton Coleman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma

Stephen Opat, Alessandra Tedeschi, Kim Linton, Pamela McKay, Bei Hu, Henry Chan, Jie Jin, Magdalena Sobieraj-Teague, Pier Luigi Zinzani, Morton Coleman, Catherine Thieblemont, Peter Browett, Xiaoyan Ke, Mingyuan Sun, Robert Marcus, Craig A. Portell, Kirit Ardeshna, Fontanet Bijou, Patricia Walker, Eliza A. Hawkes, Sally Mapp, Shir-Jing Ho, Dipti Talaulikar, Ke-Shu Zhou, Melannie Co, Xiaotong Li, Wenxiao Zhou, Massimo Cappellini, Chris Tankersley, Jane Huang, Judith Trotman
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (23): 6323–6332.
DOI: https://doi.org/10.1158/1078-0432.CCR-21-1704
Published: 01 December 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Overcoming the Response Plateau in Multiple Myeloma: A Novel Bortezomib-Based Strategy for Secondary Induction and High-Yield CD34+ Stem Cell Mobilization

Ruben Niesvizky, Tomer M. Mark, Maureen Ward, David S. Jayabalan, Roger N. Pearse, Megan Manco, Jessica Stern, Paul J. Christos, Lena Mathews, Tsiporah B. Shore, Faiza Zafar, Karen Pekle, Zhaoying Xiang, Scott Ely, Donna Skerret, Selina Chen-Kiang, Morton Coleman, Maureen E. Lane
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (6): 1534–1546.
DOI: https://doi.org/10.1158/1078-0432.CCR-12-1429
Published: 14 March 2013
View article
PDF
Includes: Supplementary data
Journal Articles

MAGE-A Inhibits Apoptosis in Proliferating Myeloma Cells through Repression of Bax and Maintenance of Survivin

Tricia Nardiello, Achim A. Jungbluth, Anna Mei, Maurizio DiLiberto, Xiangao Huang, Ania Dabrowski, Valéria C.C. Andrade, Rebecca Wasserstrum, Scott Ely, Ruben Niesvizky, Roger Pearse, Morton Coleman, David S. Jayabalan, Nina Bhardwaj, Lloyd J. Old, Selina Chen-Kiang, Hearn Jay Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4309–4319.
DOI: https://doi.org/10.1158/1078-0432.CCR-10-1820
Published: 05 July 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Activities of SYK and PLCγ2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib

Zibo Song, Pin Lu, Richard R. Furman, John P. Leonard, Peter Martin, Lauren Tyrell, Francis Y. Lee, Daniel M. Knowles, Morton Coleman, Y. Lynn Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (2): 587–599.
DOI: https://doi.org/10.1158/1078-0432.CCR-09-1519
Published: 14 January 2010
View article
PDF
Journal Articles

Epratuzumab: Targeting B-Cell Malignancies through CD22

Morton Coleman, David M. Goldenberg, Abby B. Siegel, Jamie C. Ketas, Michelle Ashe, Jennifer M. Fiore, John P. Leonard
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3991s–3994s.
Published: 31 August 2009
View article
Journal Articles

Phase I to III Trials of Anti–B Cell Therapy in Non–Hodgkin's Lymphoma

Peter Martin, Richard R. Furman, Morton Coleman, John P. Leonard
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5636s–5642s.
DOI: https://doi.org/10.1158/1078-0432.CCR-07-1085
Published: 17 September 2007
View article
PDF
Journal Articles

Magnitude of Stromal Hemangiogenesis Correlates with Histologic Subtype of Non–Hodgkin's Lymphoma

Jia Ruan, Elizabeth Hyjek, Pouneh Kermani, Paul J. Christos, Andrea T. Hooper, Morton Coleman, Barbara Hempstead, John P. Leonard, Amy Chadburn, Shahin Rafii
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5622–5631.
DOI: https://doi.org/10.1158/1078-0432.CCR-06-1204
Published: 04 October 2006
View article
PDF
Journal Articles

The Radioisotope Contributes Significantly to the Activity of Radioimmunotherapy

Thomas A. Davis, Mark S. Kaminski, John P. Leonard, Frank J. Hsu, Mary Wilkinson, Andrew Zelenetz, Richard L. Wahl, Stewart Kroll, Morton Coleman, Michael Goris, Ronald Levy, Susan J. Knox
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (23): 7792–7798.
DOI: https://doi.org/10.1158/1078-0432.CCR-04-0756
Published: 07 December 2004
View article
PDF
Journal Articles

Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma: Phase I/II Clinical Trial Results

John P. Leonard, Morton Coleman, Jamie C. Ketas, Amy Chadburn, Richard Furman, Michael W. Schuster, Eric J. Feldman, Michelle Ashe, Stephen J. Schuster, William A. Wegener, Hans J. Hansen, Heather Ziccardi, Michael Eschenberg, Urte Gayko, Scott Z. Fields, Alessandra Cesano, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5327–5334.
DOI: https://doi.org/10.1158/1078-0432.CCR-04-0294
Published: 24 August 2004
View article
PDF